GLP-1 (Tirzepatide)
£124.99
Tirzepatide is a peptide-based medication that mimics the effects of GIP and GLP-1 hormones to support blood sugar regulation and weight management. While the FDA-approved version of Tirzepatide is sold under the brand name Mounjaro®, some licensed providers may prescribe compounded Tirzepatide through regulated compounding pharmacies when clinically appropriate.
This page is intended to provide educational information about compounded Tirzepatide, its preparation, injection guidance, and considerations for patients exploring this treatment under medical supervision.
Quantity
Disclaimer
Disclaimer: The Tirzepatide product referenced on this page refers to a compounded medication and is not FDA-approved. Compounded Tirzepatide is prepared by licensed pharmacies in accordance with Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. This information is provided for educational purposes only and does not constitute medical advice or imply equivalency to FDA-approved Mounjaro®.
Always consult with a licensed healthcare provider before starting or changing any medical treatment. We do not diagnose, treat, or cure any medical condition, and no claims are made regarding the efficacy or safety of compounded medications.
